Your session is about to expire
← Back to Search
CABA-201 for Systemic Sclerosis
Study Summary
This trial is testing a new treatment called CABA-201 for people with systemic sclerosis. The study will look at how safe and effective this treatment is.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals older than 60 years old being sought for enrollment in this study?
"This research project is open to individuals aged 18 and above but below the age of 70."
Are patients still being enrolled in this ongoing medical study?
"As indicated on clinicaltrials.gov, this particular research project is currently not open for enrollment. Initially shared on June 1st, 2024 and most recently modified on April 25th, 2024, the study has concluded its candidate search. However, it's worth noting that there are an array of other studies actively welcoming participants at this time—approximately 540 trials in total."
What criteria must individuals meet to be eligible for enrollment in this medical study?
"The clinical study aims to recruit 12 individuals aged between 18 and 70 who are presently afflicted with systemic sclerosis. Eligible participants must satisfy the subsequent conditions: Being at least 18 but no more than 70 years old, Receiving a clinical diagnosis of SSc according to the classification criteria established jointly by the American College of Rheumatology and European League Against Rheumatism in 2013, Demonstrating signs of early active disease, Presenting evidence of notable skin, pulmonary, renal or cardiac engagement."
Share this study with friends
Copy Link
Messenger